Sexually Transmitted Disease Market Size is expected to be worth around USD 171 Bn by 2032 from USD 95 Bn in 2022, growing at a CAGR of 6.17% during the forecast period from 2022 to 2032.
In 2025, the STD Market is evolving through primary care integration and linked surveillance systems. Family medicine practices now routinely include chlamydia and gonorrhea screening in annual checkups based on risk algorithms. Electronic health records (EHRs) automatically prompt providers when patients are due for testing, and results flow into public health registries with patient consent. These integrated pathways enable faster contact tracing and more efficient outbreak control.
Clinics are also incorporating expedited partner treatment (EPT) digitally—patients receive prescriptions for partners immediately. This model enhances continuity of care, streamlines preventive actions, and strengthens public health response, establishing STD testing as routine rather than reactive care.
Click here for more information: https://market.us/report/sexually-transmitted-disease-market/
Key Market Segments
Based on Disease Type
- Chlamydia
- Gonorrhea
- Herpes Simplex Virus
- Syphilis
- Human Papillomavirus
- Cancroid
- Other Diseases
Based on Location
- Laboratory Testing
- Point of Care (POC) Testing
Based on Devices
- Laboratory Devices
- Point of Care (POC) Devices
Emerging Trends
- Risk-based EHR prompts for routine STI testing during primary care visits.
- Digital delivery of EPT prescriptions for partner treatment.
- Automated reporting of positive cases to public health authorities with patient consent.
- Embedded contact tracing systems triggered by lab-confirmed STIs.
Use Cases
- A PCP sees a teen for a sports physical; EHR alerts prompt gonorrhea/chlamydia testing.
- After a chlamydia diagnosis, a partner's prescription is e-sent immediately via digital EPT.
- A clinic’s EHR auto-reports a syphilis case to the public health department.
- Patients receive text reminders to inform past partners after HIV notification.